Article
Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cancer research - 15 Dec 2008
Cooper Matthew L, Adami Hans-Olov, Grönberg Henrik, Wiklund Fredrik, Green Fiona R, Rayman Margaret P
Abstract excerpt
Selenium may affect prostate cancer risk via its plasma carrier selenoprotein P which shows dramatically reduced expression in prostate cancer tumors and cell lines. The selenoprotein P (SEPP1) Ala234 single nucleotide polymorphism (SNP) allele is associated with lower plasma selenoprotein P in men, reducing the concentration/activity of other antioxidant selenoproteins. Selenium status also modifies the effect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
